1、2022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK202211T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R KI20206)T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R KII2022123002168T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K202220222

2、022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK2020212022GDP20212020T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K0220%15%5%5%30%25%100%T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K032022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK2022202220221-50-

3、9530630358442045224492550T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K05202251-78547955805688460856648965906699470957749975100T O P1 0 0B I O-P H A R M A C E U T I

4、 C A LI N D U S T R I A LP A R K0TOP10TOP10TOP10TOP10TOP101234567-8910TOP10T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K072022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK47%2022,1151%49%024681012141618高新区（个）经开区（个）2022T

5、OP1002022TOP1002022TOP100T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K0947%8%10%5%9%21%0070809051%2022TOP100T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K102022,1127.6%202200T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R

6、I A LP A R K112022,9%202020304050202012T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K122022,1128%44%21%35%56%2022TOP100-10%20%50%80%110%050002500300028%2022TOP100T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K13

7、2022,52020年生物医药上市企业总数（个）2021年新增生物医药上市企业数（个）2022TOP10068%2%22%22%T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K142022,1164%11%25%36%2022TOP1002022TOP10036%055医药智能制造项目（个）医疗智慧服务项目（个）T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K152022,

8、112022TOP030000200400600800022TOP10021%024681012143.2T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K162022,5933746569737782022TOP1002022TOP1002022TOP01001591317 2125 293337 4145 4953 576165 6973 7781 8

9、58993 97290337465697377848%T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K172022,1169%TOP 30 30 26 15 12 11 10 10 10 902004006008002TOP100TOP10T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K

10、182022,112022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK-3 8 6 6833+8+6202147382022T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K202022,11-+”“AI+-2T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K212022,11-PCRI202050050202142352022T O P1 0 0B I

11、 O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K222022,112022TOP 100 BIO-PHARMACEUTICALINDUSTRIAL PARK:园园区区区域全国视野视野视角视角不要以园区的视野看园区、看区域、看全国而是全国的视野看区域、看城市、看园区水平视角的产业多元化是主动争取被动垂直视角的产业生态化是被动争取主动产业无限广问题无限多市场无限大城市T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K24T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K253D:T O P1 0 0B I O-P H A R M A C E U T I C A LI N D U S T R I A LP A R K26